- A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Bronchiectasis
- A Pilot Study to Evaluate the Use of the Vest® System for Treatment of Bronchiectasis Patients in the Home Setting
- A Pilot Study to Investigate Administration of Mannitol Via a Novel Dry Powder Inhaler Device
- A Prospective Study of Factors Related to Exacerbation and Mortality of Non-cystic Fibrosis Bronchiectasis in Hong Kong
- A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis
- A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method
- A Study of Home-based Pulmonary Rehabilitation and Health Coaching to Treat Bronchiectasis
- A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Food Effect of Single or Repeat Doses of GSK2793660 in Healthy Subjects
- A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis
- A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
- Acute Effects of a Flutter Device and Chest Wall Compression on Respiratory System Impedance in Bronchiectasis Patients
- Adherence to Airway Clearance. Novel Approaches to Improving Adherence
- Aetiology of Children With Bronchiectasis in China
- Airway Clearance in Bronchiectasis: is Non-Invasive Ventilation a Useful Adjunct in Moderate to Severe Disease?
- Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients
- Assessment of an Exhaled Breath Test to Detect Bronchiectasis
- Assessment of Early Outcomes of Roflumilast in Patients With Non Cystic Fibrosis Bronchiectasis
- Atorvastatin in Bronchiectasis in Patients With Pseudomonas Aeruginosa
- ATP and Capsaicin Cough Provocation Test in Chronic Cough and Bronchiectasis
- Autologous Transplantation of Bronchial Basal Cells for Treatment of Bronchiectasis
- Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections
- Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
- Bacteriology and Inflammation in Bronchiectasis
- Biological Determinants of Sputum Rheology in Chronic Airway Diseases
- Bronchiectasis Alpha-1 Augmentation Trial- Modulating Airway Neutrophil Function
- Bronchiectasis and Long Term Azithromycin Treatment
- Bronchiectasis Effect in COPD Patients
- Bronchiectasis in Chronic Obstructive Pulmonary Disease (COPD) Patients: Role of Prophylaxis
- Bronchiectasis: Evaluation of an Educational Intervention
- Bronchoalveolar Lavage for Bronchiectasis Patients With Exacerbation
- Bronchodilators on the Exercise Capacity of Bronchiectasis Patients
- Can we Reduce Hospital Attendance Without Compromising Care by the Use of Telephone Consultation
- Cardiovascular Comorbidities and Bronchiectasis
- Characterization of Airway Mucus in Bronchiectasis Patients and Healthy Controls
- Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
- Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)
- Clinimetric Properties of Outcome Measures in Bronchiectasis in the UK
- COmmunity Patients at Risk of Viral Infections Including SARS-CoV-2
- Comparison of Physical Activity Level Between Patients With Bronchiectasis and Healthy Subjects
- Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis
- Comparison of Sit-to-stand Test With Six-minute Walk Test in Bronchiectasis and Healthy Children
- Comparison of the Efficacy of Comprehensive Respiratory Physiotherapy in Children With Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis
- Comparison of Upper Extremity Exercise Capacity and ADL Between Subjects With Bronchiectasis and Healthy Controls
- Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
- COPD Patient-Powered Research Network
- COVID-19 Phobia in Patients With Bronchiectasis During Covid-19 Pandemic
- Different Phenotypes of Bronchiectasis
- Effect of AIRVO Heated Humidification in Bronchiectasis
- Effect of HFCWO Vests on Spirometry Measurements
- Effect of High Frequency Chest Wall Oscillation Vests on Spirometry Measurements
- Effect of Long Term Clarithromycin for Prevention of Exacerbations in Non-cystic Fibrosis Bronchiectasis in Asian Populations
- Effect of Roflumilast on Quality of Life, Lung Function and Mucus Properties in Patients With Bronchiectasis
- Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis
- Effects of Chest Physiotherapy (CPT) on Lung Clearance Index (LCI) in Non Cystic Fibrosis (CF) Bronchiectasis
- Effects of High Intensity Inspiratory Muscle Training on Exercise Capacity in Patients With Bronchiectasis
- Effects of Inspiratory Muscle Training in Patients With Bronchiectasis
- Effects of Traditional Chinese Medicine on Bronchiectasis Patients
- Efficacy and Safety of An’Ningpai Expectorant in Non-CF Bronchiectasis
- Efficacy and Safety of Hydrogen Inhalation on Bronchiectasis: A Randomized, Multi-center, Double-blind Study
- Efficacy and Safety of Inhaled Bronchodilator in Non-CF Bronchiectasis With Airflow Limitation
- Efficacy and Safety of Long-term Oral Staphylococcus Albicans Tablets in Patients With Bronchiectasis
- Efficacy and Safety Study of a Percussion Device to Mobilise Sputum From Respiratory Passage
- Efficacy of Azithromycin in Treatment of Bronchiectasis
- Efficacy of Budesonide-Formoterol in Bronchiectasis
- Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis
- ELTGOL and Bronchiectasis. Respiratory Therapy
- Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study
- Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
- Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
- Evaluation of Medical and Nursing Management for Bronchiectasis
- Evaluation of Oscillatory Positive Expiratory Pressure (oPEP) in Bronchiectasis and COPD
- Evaluation of Periodontal Treatment in Patients With Bronchiectasis
- Evaluation of the Effect of AZD5069 in Patients With Bronchiectasis
- Evaluation of the Effect of Yoga Training on Functional Capacity and Quality of Life in Patients With Bronchiectasis
- Evaluation Of The Lung Microbiome In NTM Bronchiectasis
- Evaluation of the Quality of Life Questionnaire-Bronchiectasis (QOL-B) in Patients With Bronchiectasis
- Exercise Capacity in Bronchiectasis Resection
- Exercise Capacity in Patients With Cystic Fibrosis vs. Non-cystic Fibrosis Bronchiectasis
- Exercise Training in Patients With Non-cystic Fibrosis (CF) Bronchiectasis
- Exhaled Breath Condensate Assessment in Stable Non-Cystic Fibrotic Bronchiectasis
- Expert Patient Self-management Programme Versus Usual Care in Bronchiectasis
- Expiratory Muscle Training in Bronchiectasis
- Feasibility of Interval Exercise in Bronchiectasis
- Feasibility Study of the AffloVest in Bronchiectasis
- Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial
- Functional Respiratory Imaging in Bronchiectasis
- HFNC in Management of Bronchiectasis Exacerbation
- High Dose Inhaled Mannitol Study
- Hypertonic Saline (6%) Versus Isotonic Saline (0.9%) in Bronchiectasis
- Identification of Microbiome of Bronchiectasis in Chinese Population.
- Impact of Chronic Air Pollution on Non-cystic Fibrosis Bronchiectasis
- In-exsufflator Cough Assist Device in Patients With Symptomatic Bronchiectasis
- Inhalation Flow Rate-study
- Inhaled A1AT in Adult Stable Bronchiectasis
- Inhaled Mannitol as a Mucoactive Therapy for Bronchiectasis
- Inhaled Molgramostim (rhGM-CSF) in Healthy Adult Subjects
- Inspiratory Flow and Volumes in Bronchiectatics
- Integrating Electronic Patient Reported Biometric Measures (ePReBMs) From Wearable Devices in Respiratory Diseases
- Investigating the Clinical Features and Prognosis of Bronchiectasis Adult Patients
- Investigation of Dynamic Hyperinflation and Its Relationship With Functional Exercise Capacity in Children With Bronchiectasis
- Is a Single Daily Session Combining HS and ACTs Sufficient to Obtain Long-term Clinical Benefits in Bronchiectasis?
- Is Regular Chest Physiotherapy an Effective Treatment in Severe, Non Cystic Fibrosis Bronchiectasis?
- Lidocaine Administration During Flexible Bronchoscopy and Endobronchial Ultrasound
- Long Term Nebulised Gentamicin in Patients With Bronchiectasis
- Long-term Airway Clearance Therapy in Non-cystic Fibrosis Bronchiectasis
- Long-term Prognosis of Children With Bronchiectasis Treated With Low-dose Erythromycin Intervention
- Longitudinal Study of Helium-3 and Xenon-129 Magnetic Resonance Imaging
- Lung Clearance Index (LCI) in Pediatric Patients With Obstructive Lung Disease
- Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
- Lung Dispersing, Turbid Descending and Gut Clearing Decoction for Bronchiectasis
- Macrolide Mediates Pulmonary Infection of Pseudomonas Aeruginosa
- Macrolides in COPD- Bronchiectasis Overlap
- Metabolomic Analysis of Exhaled Breath Condensates in Patients With COPD and Bronchiectasis
- Microbial Colonization Distribution and Adaptive Evolution of Lower Respiratory Tract in Bronchiectasis Patients.
- Microbiology and Treatment Outcome of Acute Exacerbation of Bronchiectasis in Hong Kong
- Mucus Solids Concentration in Patients With Bronchiectasis
- Oscillating PEP vs Autogenic Drainage in People With Bronchiectasis
- Pain Mechanisms in Patients With Bronchiectasis
- PEP Breathing Versus Incentive Spirometry on Dyspnea and Sputum Profile in Bronchiolectasis Patients
- Pharmacokinetic Evaluation and Tolerability of Dry Powder Tobramycin by a Novel Device in Patients With Non Cystic Fibrosis Bronchiectasis
- Physical Activity in Bronchiectasis
- Physical Capacity in Patients With Bronchiectasis Before and After Rehabilitation Program
- Physiological Effects of Expiration With the Glottis Open in Lateral Posture (ELTGOL) and Flutter Valve in Patients With Bronchiectasis
- Prediction of Pulmonary Rehabilitation Outcomes in Patients With Chronic Respiratory Disease Based on Metabolomics: a Prospective Cohort Study
- Predictors of Physical Activity Performance and Dynamic Hyperinflation in Patients With Bronchiectasis
- Prevalence and Characteristics of Patients With Bronchiectasis Comorbid Nontuberculous Mycobacteria
- Prevalence of Bronchiectasis in COPD Patients
- Prevalence of Respiratory Impairment During IBD
- Prevention of Bronchiectasis in Infants With Cystic Fibrosis
- Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis
- Prognosis of Bronchiectasis in Children–A Multicenter Prospective Cohort Study
- Pulmonary Rehabilitation in Non Cystic Fibrosis Bronchiectasis
- Pulmonary Rehabilitation in Non-Cystic Fibrosis Bronchiectasis
- Pulmonary Rehabilitation Program (PRP) Versus PRP Plus Nutritional Supplementation in Patients With Bronchiectasis
- Randomised Open Label Trial of Hypertonic Saline and Carbocisteine in Bronchiectasis (CLEAR)
- Reaction Time and Postural Control in Individuals With Cystic Fibrosis and Bronchiectasis
- Respiratory Mechanics Effects of Flutter Valve in Bronchiectasis Patients
- Respiratory Muscle Strength in Bronchiectasis: Repeatability and Reliability
- Role of Innate Immunity in Non-Cystic Fibrosis Bronchiectasis
- Role of Pseudomonas Aeruginosa Biofilms in Exacerbations in Patients With Bronchiectasis With and Without Chronic Obstructive Pulmonary Disease
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis
- Safety and Efficacy of Bronchitol in Bronchiectasis
- Safety and Efficacy of Oral BAY85-8501 in Patients With Non-CF (Cystic Fibrosis) Bronchiectasis
- Safety and Potential Efficacy of Human Mesenchymal Stem Cells in Non‐Cystic Fibrosis Bronchiectasis
- Safety and Tolerability Study of 2 Dose Level of Arikayce™ in Patients With Bronchiectasis and Chronic Infection Due to Pseudomonas Aeruginosa.
- Safety, Efficacy and PK/PD of POL7080 in Patients With Exacerbation of Non-cystic Fibrosis Bronchiectasis.
- Safety, Tolerability and Efficacy of S-1226 in Cystic Fibrosis and Non CF Bronchiectasis
- Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis
- Seoul National University Airway Registry
- Short-and Long-term Effects of a Home-based Rehabilitation Program in Patients With Bronchiectasis
- Sputum Clearance Effects of Hypertonic Saline in Non-cystic Fibrosis Bronchiectasis
- Study of Bronchiectasis and Associated Cardiovascular Comorbidities
- Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QBW251 in Subjects With Bronchiectasis
- Study of the Effect of FLUTTER® VRP1 (PEP and Oscillating High Frequency).
- Study on the Influence of Climatic and Environmental Factors on Respiratory Diseases in Sanya, Hainan Province, China.
- Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo
- Sustained Effects of Hypertonic Saline on Mucociliary Clearance in Subjects With Chronic Bronchitis
- Target Validation and Discovery in Idiopathic Bronchiectasis
- Targeted AntiBiotics for Chronic Pulmonary Diseases
- Temperature Recording in Lungs of Volunteers With and Without Pulmonary Diseases
- The BRIDGE Study – Bronchiectasis Research Involving Databases, Genomics and Endotyping
- The Effect of Bronchiectasis on the Exacerbation and Mortality in COPD
- The Effect of Different Virtual Reality-Based Exercise Trainings on Pulmonary Function, Respiratory and Peripheral Muscle Strength, Functional Capacity and Balance in Children With Bronchiectasis
- The Effect of Immediate Smoking Cessation Interventions for Smokers With Chronic Airway Diseases
- The Effect of Long Term Therapy With High Flow Humidification Compared to Usual Care in Patients With Bronchiectasis (BX)
- The Effect of Proprioceptive Neuromuscular Facilitation (PNF) Technique for Children With Chronic Pulmonary Diseases.
- The Effect of Theophylline in the Treatment of Bronchiectasis
- The Establishment of China Bronchiectasis Registry and Research Collaboration
- The Long Term Effect of Inhaled Hypertonic Saline (6%) in Patients With Non Cystic Fibrosis Bronchiectasis
- The Prevalence and Impact of Depression and Anxiety Symptoms in Patients With Non-CF Bronchiectasis
- The Prevalence of Gastro-oesophageal Reflux in Chronic Lung Disease
- The PROspective German NOn-CF bronchiectaSIS Patient Registry
- The Role of Airway Microbiota on Clinical Phenotypes and Disease Severity in Bronchiectasis
- The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
- The Role of Viral Infection in Acute Exacerbations of Non-cystic Fibrosis Bronchiectasis in Adults
- The SENSOR Study: A Mixed-methods Study of SElf-management Checks to Predict exacerbatioNs of Pseudomonas Aeruginosa in Patients With Long-term reSpiratORy Conditions
- Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis
- Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa
- Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.
- Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
- Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
- VX-770 for the Treatment of Chronic Bronchitis
Clinical Trials
- 129Xe MRI in Pediatric Population With BPD
- A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
- A Study of Tobacco Smoke and Children With Respiratory Illnesses
- Aerosolized Albuterol Use in Severe BPD
- Antecedents of Bronchopulmonary Dysplasia
- Assessment of Lung Aeration at Birth
- Assessment of Lung Structure and Function of Infants Born Prematurely
- Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease
- Azithromycin in the Prevention of Lung Injury in Premature Newborn
- Baby Lung: an Observational Study
- Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
- Body Weight Growth After Birth and Bronchopulmonary Dysplasia
- BPD Saturation TARgeting
- Bronchopulmonary Disease (BPD) Patient Registry
- Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD
- Clinic Features and Outcome of BPD (SGBPD)
- Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC
- Comparison of Classification Standards of BPD in Premature Infants
- Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns
- Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial
- Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants – Effect on Respiratory Morbidity
- Corticosteroid Use in Premature Babies and Lung Ultrasonografi Use in the Progression to Bronchopulmonary Dysplasia
- CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial
- Delivery Room CPAP in Extremely Low Birth Weight Infants
- Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
- Developmental Sequelae of Severe Chronic Lung Disorders
- Dexamethasone Therapy in VLBW Infants at Risk of CLD
- Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
- Early Caffeine in Preterm Neonates
- Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
- Early Versus Late Caffeine for ELBW Newborns
- Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
- Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
- Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
- Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
- Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
- Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
- Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China
- Estimating Length of Endotracheal Tube Insertion Using Gestational Age or Nasal-Tragus Length in Newborn Infants
- Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
- Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
- Exposure to Plasticisers in the Neonatal Intensive Care Unit
- Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
- Fluid Filled Lung Oxygenation Assistance Trial
- Follow-up Results of Newborns With Tracheostomy
- Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
- Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
- Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
- Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
- Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
- Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
- Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
- Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants
- Growth of Airways and Lung Tissues in Premature and Healthy Infants
- High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation
- High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.
- High Frequency Ventilation in Premature Infants (HIFI)
- Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia
- Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia
- Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
- Hydrocortisone for BPD
- Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia
- Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease
- Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia
- Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
- Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
- Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
- Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
- Inhaled Beclomethasone to Prevent Chronic Lung Disease
- Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia
- Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
- Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
- Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
- Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
- Inhaled NO in Prevention of Chronic Lung Disease
- Inhaled Treatment for Bronchopulmonary Dysplasia
- Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation
- Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
- Intratracheal Budesonide/Surfactant Prevents BPD
- Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia
- Investigation of Polymorphisms in Bronchopulmonary Dysplasia In Turkish Population
- L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
- Late Sequelae of Bronchopulmonary Dysplasia
- Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study
- Lung Ultrasound for Early Identification of Preterm Infants With Bronchopulmonary Dysplasia
- Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
- Management of Hyponatremia in Preterm Infants on Diuretics
- Mesenchymal Stem Cells for The Treatment of Bronchopulmonary Dysplasia in Infants
- Montelukast in Very Low Birthweight Infants
- MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children
- MRI in BPD Subjects
- MRI of Lung Structure and Function in Preterm Children
- Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD
- Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns
- NAVA vs. CMV Crossover in Severe BPD
- NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)
- Neolifes Heart – Pulmonary Hypertension in Preterm Children
- Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation
- Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes
- Non-invasive Respiratory Support in Preterm Infants
- Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
- p16Ink4a in Bronchopulmonary Dysplasia in Children
- PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
- Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children
- Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
- Phase 1 Trial of Inhaled Tobramycin in BPD
- Phase 1b/2 Study on AT-100 Intervention (rhSP-D) in Preterm Neonates at High Risk for Development of Bronchopulmonary Dysplasia (BPD)
- Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
- Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia
- Physiologic Definition of Bronchopulmonary Dysplasia
- Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
- Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
- Post-hospitalization Nursing Effectiveness (PHONE) Study
- Prediction for Bronchopulmonary Dysplasia
- Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
- Premature Birth and Its Sequelae in Women
- PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
- Preterm Infant Inhaled Albuterol Dosing
- Prolonged Outcomes After Nitric Oxide (PrONOx)
- Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
- Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
- Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes
- Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood
- Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants
- Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
- Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
- Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.
- Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia
- Respiratory Outcome at Adolescence of Very Low Birthweight Infants
- Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
- Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia
- Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) – a US Study
- Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
- Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
- Safety of Sildenafil in Premature Infants
- Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
- Seattle-PAP Bubble Nasal CPAP and Work of Breathing
- Stem Cells for Bronchopulmonary Dysplasia
- Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
- Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
- Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator
- Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia
- Surfactant Administration During Spontaneous Breathing
- SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
- The Budesonide in Babies (BiB) Trial
- The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
- The Effects of Position on the Oxygenation Instability of Premature Infants as Documented by SpO2 Histograms
- The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
- The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
- The Role of Transthoracic Echocardiography in Diagnosis of Pulmonary Hypertension of Infants With Bronchopulmonary Dysplasia
- Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia
- Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease – The AD-ON Study
- Transpyloric Feeding in Severe Bronchopulmonary Dysplasia
- Trial II of Lung Protection With Azithromycin in the Preterm Infant
- Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
- Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
- Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
- Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants
- Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants
- Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
- Work of Breathing During Non-invasive Ventilation in Premature Neonates
- Work of Breathing in Premature Infants at Discharge
- A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease
- Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Buerger’s Disease
- Contrast Enhanced Ultrasound and Muscle
- Evaluation of Botulinum TOXin Type A in the Treatment of Buerger’s Disease
- Individual Patient Expanded Access IND for Selexipag (Uptravi) in Participants With Non-healing Wound, Buerger’s Disease
- Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia
- Safety and Efficacy Study of Autologous BM-MNC Processed by Two Methods for Treating Patients With Chronic Limb Ischemia
- TACT-NAGOYA: Therapeutic Angiogenesis Using Cell Transplantation
- Treatment of Thromboangiitis Obliterans (Buerguer’s Disease) With Bosentan
- A Phase 2/3 Study of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid (BALLAD)
- A Phase 3 Study to Evaluate the Long-term Safety, Tolerability and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
- A Proof-of-Concept Study of Topical AC-203 in Patients With Bullous Pemphigoid
- A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
- A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.
- Azathioprine or Mycophenolate Mofetil for Bullous Pemphigoid
- Bullous Pemphigoid Induced by antiPD-1/PDL-1 Therapy
- Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
- Dipeptidyl Peptidase-IV Inhibitors, Risk Factor for Development of Bullous Pemphigoid?
- Efficacy and Safety of Dupilumab in Patients With Bullous Pemphigoid
- Efficacy and Safety of Omalizumab in Bullous Pemphigoid
- Efficacy and Safety of Rituximab Combined With Omalizumab in Patients With Bullous Pemphigoid
- Efficacy and Safety of Ustekinumab in Bullous Pemphigoid
- Efficiency and Tolerance of Rituximab (mabthéra) in Bullous Pemphigoid
- Evaluation of Fluid Retention Due to Superpotent Topical Corticosteroid
- Explore the Mechanisms of Pruritus in Bullous Pemphigoid Patients During Remission
- Impact of Neurological Diseases on the Prognosis of Bullous Pemphigoid: A Retrospective Study of 178 Patients
- Influence of Dermocorticoids on Bone Mineral Density in Patients With Bullous Pemphigoid
- Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid
- Ixekizumab in the Treatment of Bullous Pemphigoid
- Leflunomide Associated With Topical Corticosteroids for Bullous Pemphigoid
- Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP)
- Observational Study Assessing Outcomes, Treatment Patterns and Related Costs in Patients in Bullous Pemphigoid
- Rituximab in the Treatment of Patients With Bullous Pemphigoid
- rVA576 in Adult Mild to Moderate Bullous Pemphigoid Subjects
- Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment
- Telederm and Bullous Pemphigoid
- The Association of Bullous Pemphigoid With Dipeptidyl-peptidase 4 Inhibitors
- Topical Steroids Alone or Associated With Methotrexate in Bullous Pemphigoid
- Treatment of Bullous Pemphigoid With Avdoralimab (IPH5401), an Anti-C5aR1 Monoclonal Antibody
- Validation of a Simplified Severity Score (Investigator Global Assessment: IGA) in Bullous Pemphigoid
- Acupuncture Versus Clonazepam in Burning Mouth Syndrome
- Alpha Lipoic Acid for Burning Mouth
- Botulinum Toxin in Burning Mouth Syndrome
- Burning Mouth Disorder (BMD) – A Neuropathic Pain Disorder
- Burning Mouth Syndrome – New Diagnostic Criteria and Treatment
- Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome
- Effectiveness of Mucolox® and Clonazepam in Treatment of Burning Mouth Syndrome
- Efficacy of Melatonin in Burning Mouth Syndrome (BMS)
- Efficacy of Nalbuphine and Naloxone Administered as Nose Sprays in the Treatment of Orofacial Pain
- Efficacy of Transcranial Magnetic Stimulation (TMS) in Chronic Idiopathic Pain Disorders
- Evaluation and Treatment of Oral Soft Tissue Diseases
- Head Yuanshi Dian Therapy in Burning Mouth Syndrome
- Hormonal Status and Quality of Life in Female Postmenopausal Patients With Burning Mouth Syndrome
- Impact of Alpha Lipoic Acid Efficacy in Burning Mouth Syndrome
- Low Level Laser Therapy Plus Topical Clonazepam Treatment to Burning Mouth Symdrome
- Neurogenic Mechanisms in Burning Mouth Syndrome
- Opiorphin Levels in Fluids of Burning Mouth Syndrome Patients (OPIODYN)
- Salivary Melatonin Levels and Sleep Quality in Patients With Burning Mouth Syndrome
- Study Evaluating the Laser Diode Effect Burning Mouth Syndrome
- Thalidomide to Treat Oral Lesions in HIV-Infected Patients
- The Efficacy of N-acetyl-cysteine in the Treatment of Burning Mouth Syndrome
- The Role of Xerostomia in Burning Mouth Syndrome: Case – Control Study
- Therapeutic Options for Treatment of Burning Mouth Syndrome
- Thermography and Burning Mouth Syndrome
- Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine
- CADASIL Registry Study
- Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
- CERebrolysin In CADASIL
- Development of New Biomarkers With Magnetic Resonance Imaging for Longitudinal Studies in CADASIL Angiopathy
- Efficacy and Safety of Tocotrienols in CADASIL
- Generation of a Cellular Model of CADASIL From Skin Fibroblasts
- Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Impact of tDCS on Cerebral Autoregulation
- Registry for CADASIL
- Research Study on Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
- Retina is a Marker for Cerebrovascular Heath
- Safety and Efficacy of Fremanezumab for Migraine in Adult CADASIL
- Safety Study of Dabigatran in CADASIL
- A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis Patients
- Better Evidence and Translation for Calciphylaxis
- Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and Outcome
- Efficacy of Lanthanum Carbonate in Calciphylaxis
- European Calciphylaxis Registry Network
- Evaluation of Vitamin K Supplementation for Calcific Uremic Arteriolopathy
- Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium Thiosulfate
- Partners Calciphylaxis Biobank
- Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)
- Phase 2 Study With SNF472 in Calciphylaxis Patients
- Phase 3 Study of SNF472 for Calciphylaxis
- Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)
- Stem Cells for Uremic Calciphylaxis Patients
- The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National Cohort
- A Natural History Study of Canavan Disease
- A Study of AAV9 Gene Therapy in Participants With Canavan Disease
- Canavan-Single Patient IND
- GTA-Glyceryltriacetate for Canavan Disease
- Lithium and Acetate for Canavan Disease
- Natural History Study of Patients With Canavan Disease, CAN Inform
- Oral Glyceryl Triacetate (GTA) in Newborns With Canavan
- rAAV-Olig001-ASPA Gene Therapy for Treatment of Children With Typical Canavan Disease
- 68Ga-Dotatoc Positron Emission Tomography (PET) for Somatostatin Receptor-Positive Neuroendocrine Tumors (NETs)
- A Combination Study to Determine the Safety and Efficacy of Panzem NCD With Avastin in Metastatic Carcinoid Tumors
- A Phase II Study of Ramucirumab With Somatostatin Analog Therapy in Patients With Advanced, Progressive Carcinoid Tumors
- A Safety Study of 212Pb-Pentixather Radioligand Therapy
- A Study of Axitinib in Advanced Carcinoid Tumors
- A Study of Sunitinib Versus Placebo in Combination With Lanreotide in Patients With Progressive Advanced/Metastatic Midgut Carcinoid Tumors
- Active Surveillance in Early Lung Cancer
- Bronchoscopic Laser Ablation of Peripheral Lung Tumors
- Cabozantinib and Nivolumab for Carcinoid Tumors
- Carcinoid Heart Disease and Peptide Receptor Radiotargetted Therapy
- Clinical and Pathologic Studies in Neuroendocrine Tumors
- Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion
- Endoscopic Treatment of Bronchial Carcinoid Tumors
- Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor
- Nintedanib in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors
- Nivolumab With Ipilimumab in Subjects With Neuroendocrine Tumors
- Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
- Personalized PRRT of Neuroendocrine Tumors
- Physical Activity Intervention Before and After Surgery in Older Adults With Lung Cancer and Their Family Caregivers
- Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma
- Study Evaluating SOM230 in Patients With Metastatic Carcinoid Tumors
- Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)
- Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease
- Ziv-Aflibercept for Advanced Progressive Carcinoid Tumors
- A Safety and Efficacy Study of CNTO 328 in Patients With B-Cell Non-Hodgkin’s Lymphoma, Multiple Myeloma, or Castleman’s Disease
- A Study to Provide RoActemra/Actemra (Tocilzumab) to Patients With Multicentric Castleman’s Disease Who Demonstrated Benefit From Previous RoActemra/Actemra Treatment
- Castleman Disease Collaborative Network Biobank
- International Registry for Patients With Castleman Disease
- Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
- Unicentric Form of Castleman Disease – Surgery Therapy Benefit